ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1241

Optimizing Communication of Methotrexate (MTX) Side Effects: A Patient-Centered Approach Focused on Learning Styles and Preferred Language

Veena Patel1, Sophia Dove2 and Veronica Chavez3, 1Dell Medical School - UT Health Austin, Austin, TX, 2Moody College of Communication, The University of Texas at Austin, Austin, TX, 3University of Texas - Dell Medical School, Austin, TX

Meeting: ACR Convergence 2024

Keywords: education, patient, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Methotrexate (MTX) remains the first-line treatment for RA due to its effectiveness and affordability, but communicating its complex regimen and instructions can be challenging, especially for patients with low health literacy or limited English proficiency. This project aims to gather direct feedback from underserved English and Spanish speaking patients on their preferences and recommendations for learning about MTX.  

Methods: Patients on MTX seen in clinic in the past 6 months were recruited from our rheumatology clinic located in a federally qualified health center. Our study survey was conducted via telephone between May-September 2023. Phone language translation services were used when needed.

The study survey created by our research team had four sections: demographics, methotrexate comprehension, VARK learning style items1 and patient empowerment open-ended questions (Figure 1). To assess health literacy, we utilized the BRIEF screening tool2.

To interpret answers to VARK questions, each answer choice is associated with a respective learning style (V=visual, A=auditory, R=reading, K=kinesthetic). Responses were counted individually. The open-ended responses were reviewed by the authors and themes were created. A bubble chart was created from direct feedback from patients.

Results: Twenty-three patients, 10 English and 13 Spanish-speaking, completed the survey. Most patients were Hispanic women with a high school level education who reported adequate health literacy (70%) (Table 1). Many showed correct use of folic acid and reason for lab monitoring. Fifty percent were unable to recall side effects correctly, with only 23% of Spanish-speakers able to. English-speakers reported strongest preference for kinesthetic (35%) and auditory learning styles (33%).  Spanish-speakers preferred reading (44%) and auditory learning styles (27%). Both showed less preference for visual learning style (15%) based on VARK questions.

Spanish-speakers highlighted a need for clearer explanations about potential side effects. Common advice for new patients included patience in allowing medication to take full effect and staying consistent with taking MTX. Many suggested sharing lifestyle characteristics with their doctor to help set expectations around the best ways to take MTX.

Open-ended responses mention usefulness in incorporating images into educational materials for patients new to MTX, particularly in Spanish speakers, who also mention importance of using positive language in learning materials.

Conclusion: Our study provided valuable insights directly from patients showing a preference for a multimodal approach to learning with differences among English and Spanish speakers. We can use this information for the next phase of our project by creating tailored, patient-centered educational materials for our patients starting MTX, aiming to enhance adherence and comprehension from the outset of treatment.

1. Leite WL, et al. Attempted validation of the scores of the VARK: Learning styles inventory with multitrait–multimethod confirmatory factor analysis models. Educ Psychol Meas 2010, 70:323–339.

 2. Haun J, et al. Testing the BRIEF health literacy screening tool. Fed Pract 2009; 26: 24-31.  

Supporting image 1

Figure 1. Survey Questions

Supporting image 2

Table 1. Patient Characteristics and Survey Responses

Supporting image 3

Figure 2. Bubble chart with patient preferences for educational materials.
Comparison of Spanish and English speakers of words/themes used to answer open-ended question: “If you were designing a flyer for other patients about methotrexate, what words, pictures, or other features would you use or avoid?


Disclosures: V. Patel: None; S. Dove: None; V. Chavez: None.

To cite this abstract in AMA style:

Patel V, Dove S, Chavez V. Optimizing Communication of Methotrexate (MTX) Side Effects: A Patient-Centered Approach Focused on Learning Styles and Preferred Language [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/optimizing-communication-of-methotrexate-mtx-side-effects-a-patient-centered-approach-focused-on-learning-styles-and-preferred-language/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optimizing-communication-of-methotrexate-mtx-side-effects-a-patient-centered-approach-focused-on-learning-styles-and-preferred-language/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology